6-145805856-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032145.5(FBXO30):āc.550C>Gā(p.Gln184Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032145.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO30 | NM_032145.5 | c.550C>G | p.Gln184Glu | missense_variant | 2/3 | ENST00000237281.5 | NP_115521.3 | |
EPM2A-DT | NR_038246.1 | n.53-22505G>C | intron_variant, non_coding_transcript_variant | |||||
FBXO30 | NM_001348092.2 | c.550C>G | p.Gln184Glu | missense_variant | 2/3 | NP_001335021.1 | ||
FBXO30 | XM_047419398.1 | c.658C>G | p.Gln220Glu | missense_variant | 2/3 | XP_047275354.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO30 | ENST00000237281.5 | c.550C>G | p.Gln184Glu | missense_variant | 2/3 | 1 | NM_032145.5 | ENSP00000237281 | P1 | |
EPM2A-DT | ENST00000629681.1 | n.91-3922G>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461764Hom.: 0 Cov.: 34 AF XY: 0.0000165 AC XY: 12AN XY: 727186
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.550C>G (p.Q184E) alteration is located in exon 2 (coding exon 1) of the FBXO30 gene. This alteration results from a C to G substitution at nucleotide position 550, causing the glutamine (Q) at amino acid position 184 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at